• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[端粒酶在人类和仓鼠胰腺癌发生中的作用]

[The role of telomerase for pancreatic carcinogenesis in human and hamster].

作者信息

Tsutsumi M, Tsujiuchi T, Konishi Y

机构信息

Department of Oncological Pathology, Cancer Center, Nara Medical University.

出版信息

Nihon Rinsho. 1998 May;56(5):1234-8.

PMID:9613129
Abstract

Telomerase activity and terminal restriction flagment (TRF) length were investigated in human and hamster pancreatic duct adenocarcinomas. In the hamster primary and transplantable pancreatic carcinomas and cell lines, telomerase activity increased 86 to 215.7 times relative to the levels in normal spleen and pancreas, and reduction of TRF length was observed. In 38 human pancreatic ductal carcinomas, 32 (84%) exhibited increased telomerase activities with no apparent relation to the histological type of tumor, tumor size, regional lymph node involvement and distant metastasis. These results suggest that telomerase play an important role for pancreatic duct carcinogenesis.

摘要

对人及仓鼠胰腺导管腺癌中的端粒酶活性和末端限制片段(TRF)长度进行了研究。在仓鼠原发性和可移植性胰腺癌及细胞系中,相对于正常脾脏和胰腺中的水平,端粒酶活性增加了86至215.7倍,并且观察到TRF长度缩短。在38例人胰腺导管癌中,32例(84%)表现出端粒酶活性增加,且与肿瘤的组织学类型、肿瘤大小、区域淋巴结受累及远处转移无明显关系。这些结果表明端粒酶在胰腺导管癌发生中起重要作用。

相似文献

1
[The role of telomerase for pancreatic carcinogenesis in human and hamster].[端粒酶在人类和仓鼠胰腺癌发生中的作用]
Nihon Rinsho. 1998 May;56(5):1234-8.
2
Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines.
Mol Carcinog. 1997 Mar;18(3):153-9. doi: 10.1002/(sici)1098-2744(199703)18:3<153::aid-mc4>3.0.co;2-g.
3
Increased telomerase activities in human pancreatic duct adenocarcinomas.人胰腺导管腺癌中端粒酶活性增加。
Jpn J Cancer Res. 1997 Oct;88(10):971-6. doi: 10.1111/j.1349-7006.1997.tb00317.x.
4
Telomerase activity and alterations in telomere length in human brain tumors.人脑肿瘤中的端粒酶活性及端粒长度改变
Cancer Res. 1998 May 15;58(10):2117-25.
5
[Telomerase activity in infiltration ductal carcinoma of breast].
Zhonghua Yi Xue Za Zhi. 1998 Jul;78(7):515-6.
6
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.端粒酶活性是区分恶性胰腺囊性肿瘤与良性肿瘤及假性囊肿的有用标志物。
J Surg Res. 1999 Dec;87(2):171-7. doi: 10.1006/jsre.1999.5699.
7
Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.非小细胞肺癌中端粒酶表达与末端限制片段长度比值的相关性——一种校正测量方法及其临床意义
Eur J Cardiothorac Surg. 2004 Aug;26(2):425-31. doi: 10.1016/j.ejcts.2004.04.029.
8
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.与非恶性病理状态相比,胰腺导管癌中端粒酶水平升高。
Clin Cancer Res. 1997 Jun;3(6):993-8.
9
Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.人食管癌细胞中的端粒长度、端粒酶活性及端粒酶RNA表达:与细胞增殖、分化及对抗癌药物的化疗敏感性的相关性
Anticancer Res. 1998 May-Jun;18(3A):1465-72.
10
Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Cancer Res. 1997 Jan 15;57(2):326-31.